CMS's 2026 Final Rule implements the Medicare Drug Price Negotiation Program with the Medicare Transaction Facilitator, affecting Part D drug pricing and pharmacy reimbursement processes.
Congressional budget cuts proposed by House Republicans raise concerns about potential impacts on Medicare, Medicaid, and Veterans Affairs funding. Key debates focus on program efficiency versus benefit reductions.
Learn how proposed $880 billion Medicaid cuts could affect Iowa's Medicaid program, healthcare access, and economic stability, including job losses and state revenue decline.
Dr. Mehmet Oz confirmed as CMS Administrator with mandate to protect and grow Medicare Advantage, improving care and reducing costs for seniors.
In 2024, UnitedHealth CEO Andrew Witty earned $26.3 million, leading health insurance payer executive compensation amid manageable Medicare Advantage costs and leadership changes in major firms.
Study reveals shifting patterns in home health care use among Medicare Advantage enrollees, highlighting implications for care quality, equity, and policy in U.S. Medicare programs.
2024 health insurer CEO pay ratios reveal top executives earning up to 370 times median staff. Medicare Advantage costs remain elevated but manageable as per insurers' financial disclosures.
Explore critical U.S. public health and policy updates affecting healthcare insurance, including COVID-19 booster guidance, AI diagnostics, Medicare Advantage reforms, and expanding HIV challenges in Texas.
Explore how the Advisory Board supports healthcare leaders with insights and strategies on industry trends, FDA approvals, AI, and health equity shaping the U.S. insurance and healthcare sectors.
Social Security in Houston faces increasing delays due to staffing cuts and higher call volumes, impacting benefit approvals and service access. Learn how these challenges affect Texas beneficiaries and federal service modernization efforts.
